EPO ends the ’10-day rule’
UPDATE as of 19 October 2023 The European Patent Office (EPO)’s ‘10-day rule’ will cease to exist from 1 November 2023 From that date, EPO communications will be deemed to be delivered on the… read more…
Nootropics revolution – patentability in the UK and EU
Data and commentary provided by Mathys & Squire has featured in an article by The Nutraceutical Business Review, providing an update on the growth of the nootropics market A condensed… read more…
Free-from controversy? IP disputes in the health and wellness foods market
Data provided by Mathys & Squire has featured in an article by Managing IP analysing the increase in demand for free-from foods and the subsequent surge in legislation An extended version of… read more…
‘Highly knowledgeable’ and ‘dynamic’ Mathys & Squire teams recommended for ‘standing out above all other firms’ in The Legal 500 2023 directory
We are delighted to announce that Mathys & Squire has maintained its ranking for the PATMA: Patent Attorneys and PATMA: Trademark Attorneys categories in the 2023 edition of The Legal 500 We are… read more…
Guidance on examining patent applications relating to artificial intelligence inventions in the UK
The UK Intellectual Property Office (UKIPO) released a guidance note for the examination of patent applications relating to artificial intelligence (AI) inventions The UKIPO has confirmed that… read more…
The role of IP in assisting the economic recovery – Case study 3: Transport
(C) Naomi Korn Associates & Mathys & Squire 2022 Some Rights Reserved These case studies are licensed for reuse under the terms of a Creative Commons Attribution Share Alike… read more…
Almost 5,000 drone patents granted last year – a 39% increase
Data and commentary provided by Mathys & Squire has featured in articles by The Manufacturer and The Patent Lawyer, providing an update on the rapid growth in drone patents that have been… read more…
J 8/20: EPO’s Board of Appeal provides written decision and reasons reconfirming AI cannot be named as inventor on European patent applications
In the latest update on the artificial intelligence (AI) inventorship saga, the legal Board of Appeal of the European Patent Office has now provided their written decision and reasons for dismissal… read more…
T 2627/17: Divergent outcomes for first and second medical use claims under Article 83 EPC
This recent decision by the European Patent Office (EPO) Boards of Appeal (T 2627/17) highlighted the way in which the ‘sufficiency of disclosure’ requirements under Article 83 EPC can lead to… read more…
